BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 3, 2012
View Archived Issues
New phase III results reported on Biogen Idec drug for MS
Read More
CO-releasing compound protects against cerebral malaria
Read More
Multikinase inhibitor from Piramal Life Sciences significantly suppresses tumor growth
Read More
New vasopressin V1B receptor antagonists designed in Japan
Read More
Boehringer Ingelheim Pharma develops new CD33-binding antibodies
Read More
Novel candidate cancer immunotherapies presented by Oxford BioTherapeutics
Read More
Amrita Therapeutics divulges new potential cancer therapies
Read More
Second-generation cyclophilin inhibitor selected for clinical development in hepatitis C
Read More
Study in Chinese children links LINE-1 methylation to congenital heart defect
Read More
Advanced Cell Technology confirms additional site for dry AMD stem cell trial
Read More
AVEO reports preliminary data from phase II ficlatuzumab combination trial
Read More
Zogenix submits NDA for Zohydro
Read More
BioAnalytica discloses novel HSP 90-targeting antibodies
Read More
Trevena enters collaboration to identify novel biased ligand molecules
Read More
Altor BioScience product to enter clinical testing for melanoma
Read More
Kyowa Hakko Kirin offers development update for first quarter 2012
Read More
Cleveland BioLabs and Incuron receive clearance for CBLC-137 trial in Russia
Read More
Quark to conduct phase IIa study of siRNA drug in open-angle glaucoma
Read More
Enrollment complete in pivotal study of oral testosterone replacement therapy
Read More
Ultragenyx reports first-in-human data on UX-001
Read More
SUMMACTA study meets primary endpoint
Read More
Genomic Health and OncoMed form alliance
Read More
Dako and Genentech to collaborate on U.S. regulatory submissions for companion diagnostics
Read More
Azelon completes phase II study of nasal spray for osteoporosis
Read More
Janssen seeks approval of Xarelto for additional indications
Read More